-->

Type something and hit enter

Pages

Singapore Investment


On

 MAHSING (8583) MAH SING GROUP BHD ? VACCINE ? + GLOVE VENTURE... POTENTIAL LIMIT UP ?!

Join our Telegram Channel : https://t.me/TriumphinBursa
November 2020, We able to pick 2x Limit Up Counters : GETS & SAMAIDEN


20 Nov 2020


 
KUALA LUMPUR (Nov 17): China National Pharmaceutical Group (Sinopharm), through GI Healthcare Resources Sdn Bhd — a joint-venture company (JVCo) with local investors — has agreed to sponsor 10,000 doses of the former's Covid-19 vaccine for Malaysian frontliners.

 
GI Healthcare Resources was represented by 
 
Tan Sri Lim Yew Loong,(LYL group, property boss) 
 
Tan Sri Leong Hoy Kum, (Founder and Chief Executive of Mah Sing Group,)
 
Sim Guan Yu & Rosli Dahlan as its advisers while Liu represented the firm in the video conference.





Technical Analysis

We can see 19/11 Price has a hike from the support trendline.
Also alerted the 1-Cross-4 Pattern.
Smart Money never left this counter yet.
End of the Flag Pattern, Breakout and Retest.


LAST MONTH :
https://www.theedgemarkets.com/article/mah-sing-start-glove-production-april-2021

KUALA LUMPUR (Oct 21): Mah Sing Group Bhd is set to commence glove production in April 2021. Mah Sing said it has commenced additional piling works to accommodate 12 units of new, high-speed glove dipping machines at its glove manufacturing factory in Kapar, Klang, to meet its targeted production date.

If you like our sharing,
Join our Telegram Channel: 
 
https://t.me/TriumphinBursa


https://klse.i3investor.com/blogs/triumphinbursa/2020-11-20-story-h1536520413-MAHSING_VACCINE_GLOVE_VENTURE_POTENTIAL_LIMIT_UP.jsp
Back to Top